Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase -: Implications for polymerase translocation and drug resistance

被引:80
|
作者
Marchand, B
Götte, M
机构
[1] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2T5, Canada
[3] McGill Univ, Dept Expt Med, Montreal, PQ H3A 2T5, Canada
关键词
D O I
10.1074/jbc.M304262200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistance to nucleoside analogue inhibitors of the reverse transcriptase of the HIV-1 often involves phosphorolytic excision of the incorporated chain terminator. Previous crystallographic and modeling studies suggested that this reaction could only occur when the enzyme resides in a pre-translocational stage. Here we studied mechanisms of polymerase translocation using novel site-specific footprinting techniques. Classical footprinting approaches, based on the detection of protected nucleic acid residues, are not sensitive enough to visualize subtle structural differences at single nucleotide resolution. Thus, we developed chemical footprinting techniques that give rise to hyperreactive cleavage on the template strand mediated through specific contacts with the enzyme. Two specific cuts served as markers that defined the position of the polymerase and RNase H domain, respectively. We show that the presence of the next correct dNTP, following the incorporated chain terminator, caused a shift in the position of the two cuts a single nucleotide further downstream. The footprints point to monotonic sliding motions and provide compelling evidence for the existence of an equilibrium between pre- and post-translocational stages. Our data show that enzyme translocation is reversible and uncoupled from nucleotide incorporation and the release of pyrophosphate. This translocational equilibrium ensures access to the pre- translocational stage after incorporation of the chain terminator. The efficiency of excision correlates with an increase in the population of complexes that exist in the pre- translocational stage, and we show that the latter configuration is preferred with an enzyme that contains mutations associated with resistance to nucleoside analogue inhibitors.
引用
收藏
页码:35362 / 35372
页数:11
相关论文
共 50 条
  • [21] Exploring the effects of active site constraints on HIV-1 reverse transcriptase DNA polymerase fidelity
    Cramer, J
    Strerath, M
    Marx, A
    Restle, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) : 43593 - 43598
  • [22] HOW TO OVERCOME RESISTANCE OF HIV-1 TO HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DECLERCQ, E
    AIDS, 1994, 8 (07) : 1020 - 1021
  • [23] Ab intio molecular dynamics studies on HIV-1 reverse transcriptase triphosphate binding site: Implications for nucleoside analog drug resistance.
    Alber, F
    Carloni, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U300 - U300
  • [24] Ab initio molecular dynamics studies on HIV-1 reverse transcriptase triphosphate binding site: Implications for nucleoside-analog drug resistance
    Alber, F
    Carloni, P
    PROTEIN SCIENCE, 2000, 9 (12) : 2535 - 2546
  • [25] Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance
    Masso, Majid
    Vaisman, Iosif I.
    BMC GENOMICS, 2013, 14
  • [26] DEOXYNUCLEOTIDE POLYMERIZATION BY HIV-1 REVERSE-TRANSCRIPTASE IS TERMINATED BY SITE-SPECIFIC STYRENE OXIDE ADDUCTS AFTER TRANSLESION SYNTHESIS
    LATHAM, GJ
    LLOYD, RS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (46) : 28527 - 28530
  • [27] Application of Site-Specific Spin Labeling for NMR Detecting Inhibitor-Induced Conformational Change of HIV-1 Reverse Transcriptase
    Seetaha, Supaporn
    Yagi-Utsumi, Maho
    Yamaguchi, Takumi
    Ishii, Kentaro
    Hannongbua, Supa
    Choowongkomon, Kiattawee
    Kato, Koichi
    CHEMMEDCHEM, 2016, 11 (04) : 363 - 366
  • [28] Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA
    Sarafianos, SG
    Clark, AD
    Das, K
    Tuske, S
    Birktoft, JJ
    Ilankumaran, P
    Ramesha, AR
    Sayer, JM
    Jerina, DM
    Boyer, PL
    Hughes, SH
    Arnold, E
    EMBO JOURNAL, 2002, 21 (23): : 6614 - 6624
  • [29] Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance
    Majid Masso
    Iosif I Vaisman
    BMC Genomics, 14
  • [30] Insertions and deletions in HIV-1 reverse transcriptase:: Consequences for drug resistance and viral fitness
    Menendez-Arias, Luis
    Matamoros, Tania
    Cases-Gonzalez, Clara E.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (15) : 1811 - 1825